Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 114.00
0.00 (0.00%)
Apr 20, 2026, 10:56 AM IDT
TLV:IMED Market Cap
TLV:IMED has a market cap or net worth of 4.6 million as of April 24, 2026. Its market cap has increased by 38.18% in one year.
Market Cap
4.60M
Enterprise Value
-4.59M
Revenue
720.49K
Ranking
n/a
PE Ratio
n/a
Stock Price
114.00
Market Cap Chart
Since December 29, 2020, TLV:IMED's market cap has decreased from 40.32M to 4.60M, a decrease of -88.59%. That is a compound annual growth rate of -33.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 4.60M | -6.48% |
| Dec 31, 2025 | 4.92M | 9.43% |
| Dec 30, 2024 | 4.49M | -2.45% |
| Dec 31, 2023 | 4.61M | -19.63% |
| Dec 27, 2022 | 5.73M | -55.66% |
| Dec 30, 2021 | 12.93M | -67.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 108.98B |
| Danel (Adir Yeoshua) | 2.86B |
| Amal Holdings A.D. | 2.38B |
| BrainsWay | 1.94B |
| Bio-View | 21.44M |
| Can-Fite BioPharma | 19.82M |
| BioLight Life Sciences | 19.45M |
| XTL Biopharmaceuticals | 18.92M |